An Estimate of Average Cost of Hypertension and its catastrophic effect on the people living with hypertension: Patients’ perception from two Hospitals in Abuja, Nigeria


  • Idris Abubakar PhD economics, Department of Economics, Faculty of Social Science University of Abuja, Federal, Capital Territory, Abuja-Nigeria. Email:
  • Obansa S.A.J Professor of economics, Department of Economics, Faculty of Social Science University of Abuja, Federal, Capital Territory, Abuja-Nigeria. email:



Hypertension, Catastrophic spending, Personal spending, Least income, Urban dwellers, Intervention scheme


Purpose of the study: The study was motivated by the high prevalence of hypertension and its associated costs of financing drugs to treating the disease. Hypertension has become a source of worry to the sufferers and caregivers, given its direct and indirect cost implications. The study specifically estimated the direct average cost of treating hypertension and verified its catastrophic effect on the sufferers in Nigeria.

Methodology: To achieve the objective, the study undertook the review of related literature on the burden of hypertension. It utilized the primary method of data collection by administering structured questionnaires to the target respondents in the University of Abuja Teaching Hospital and National Hospital, Abuja, Nigeria. Data were descriptively analysed using frequency and percentage with the aid of SPSS version 22.

Main findings: The result revealed that the average annual cost attributable to hypertension treatment is N145, 086.12 per patient. The study documented that 191(82 percent) patients undertook personal health spending. Hypertension financing was discovered to be catastrophic among 30.5 percent of the least income patients. Therefore, it concluded that the average cost of treating hypertension was high among urban dwellers and catastrophic among the least earners.

Res Research limitations/implications: The findings will be relevant for the policy framework for government relating to healthcare financing and the establishment of intervention schemes that will alleviate the burdens associated with hypertension among the sufferers. Health planners and administrators will immensely benefit from the study as the study revealed the knowledge of treating hypertension for planning purposes and reference points for both researchers and academics.

Novelty/Originality of this study: Knowledge relating to the direct cost of treating hypertension annually for intervention purposes is limited. Therefore, to touch lightly upon this, the study attempted an estimation of the average annual direct cost of treating hypertension and its associated burdens to the sufferers through a survey investigation. Findings, therefore, will advance the existing knowledge on the burden of hypertension and the policy of healthcare interventions.


Download data is not yet available.


Abegunde, O.D., & Stanciole, A. (2006).An Estimation of the Economic Impact of Chronic Non Communicable Diseases in selected countries. Working paper, World Health Organisation ; Retrieved from

Adane, E. , Atanafu, A. , & Aschalew, A. Y.(2020). The Cost of hypertension and Associated factors, university of Gondar Comprehensive Specialised Hospital Nortwest, Ethiopia, 2018. Clinico Economics and Outcomes Research Journal, 12, 133-140.

Bakare, O. Q., Akinyinka, M. R., Goodman, O., Kuyinu, Y. A., Wright, O. K., Adeniran, A., ... & Osibogun, A. (2016). Antihypertensive use, prescription patterns, and cost of medications in a Teaching Hospital in Lagos, Nigeria. Nigerian journal of clinical practice, 19(5), 668-672.

Bloom, D. E., Cafiero, E. T., McGovern, M. E., Prettner, K., Stanciole, A., Weiss, J., ... & Rosenberg, L. (2013). The economic impact of non-communicable disease in China and India: estimates, projections, and comparisons (No. w19335). National Bureau of Economic Research.

Chao, S. (2013). Economic Impact of Non-Communicable Diseases in the Caribbean.The World Bank Caribbean Health Financing Conference, November 12-14, 2013.

Dzau, V. J., & Balatbat, C. A. (2019). Future of Hypertension: The Need for Transformation. Hypertension, 74(3), 450-457.

Ekman, B. (2007). Catastrophic health payments and health insurance: Some counterintuitive evidence from one low-income country. Health policy, 83(2-3), 304-313.

Eze, C. O., & Kalu, U. A. (2014). The Prognosis of Acute Stroke in a Tertiary Health Centre in South-East Nigeria. Nigerian Journal of Medicine, 23, 306-310.

Federal Ministry of Health, (1991). National Survey on Non-communicable Diseases in Nigeria.

Gaziano, T. A., Bitton, A., Anand, S., & Weinstein, M. C. (2009). The global cost of nonoptimal blood pressure. Journal of hypertension, 27(7), 1472-1477.

Ilesanmi, O. S., Ige, O. K., & Adebiyi, A. O. (2012). The managed hypertensive: the costs of blood pressure control in a Nigerian town. Pan African Medical Journal, 12(1), 1-09.

Jha, P., Nugent, R., Varguet, S., Bloom, D., & Hum, R.(2013). Chronic Disease Assessment: Third Copenhagen Consensus, Cambridge University press.

Kado, D., Bala, K., & Dandajeh, M. A. (2016). Pareto Analysis on the Total Quality Management (TQM) Status of the Nigerian Design Firms. ATBU Journal of Environmental Technology, 9(1), 42-57.

Kengne, A. P., Mchiza, Z. J. R., Amoah, A. G. B., & Mbanya, J. C. (2013). Cardiovascular diseases and diabetes as economic and developmental challenges in Africa. Progress in Cardiovascular Diseases, 56(3), 302-313.

Kirkland, E. B., Heincelman, M., Bishu, K. G., Schumann, S. O., Schreiner, A., Axon, R. N., ... & Moran, W. P. (2018). Trends in healthcare expenditures among US adults with hypertension: national estimates, 2003–2014. Journal of the American Heart Association, 7(11), 1-09.

Krejcie, R. V., & Morgan, D. W. (1970). Determining sample size for research activities. Educational and psychological measurement, 30(3), 607-610.

Ndiyo, N.A. (2015). Fundamental of Research in Behavioural Sciences and Humanities. Calaber, Nigeria; Excel, 14ed. p288.

Charles, C. N. C., Azodo, M. N. M., & Chuku, C. A. (2014). Causes and pattern of death in a tertiary hospital in south eastern Nigeria. Sahel Medical Journal, 17(3), 102-107.

Lambo, E. (2007). Socio Economic Impact of Non communicable Diseases.

Li, R., Liang, N., Bu, F., & Hesketh, T. (2020). The Effectiveness of Self-Management of Hypertension in Adults Using Mobile Health: Systematic Review and Meta-Analysis. JMIR mHealth and uHealth, 8(3), 1-16.

Odili, A. N., & Abatta, E.O.(2015). Blood Pressure Indices, Life Style factors and Anthropometric Correlates of Casual Blood Glucose in rural Nigerian Community.Annal of African Medicine, 1(4),39-45.

Ogah O.,Okpechi, I., Chukwuonye, I.I., Akinyemi J.O., Onwubere B.J.C., Falase,A.O., Stewart, S., & Sliwa, K. (2012). Blood Pressure, Prevalence of Hypertension and Hypertension Related Complications in Nigerian Africans: A Review. World Journal of Cardiology 2012 December 26; 4(12): 327-340.

Okubadejo, N. U., Ozoh, O. B., Ojo, O. O., Akinkugbe, A. O., Odeniyi, I. A., Adegoke, O., ... & Agabi, O. P. (2019). Prevalence of hypertension and blood pressure profile amongst urban-dwelling adults in Nigeria: a comparative analysis based on recent guideline recommendations. Clinical hypertension, 25(1), 1-09.

Oyando, R., Njoroge, M., Nguhiu, P., Kirui, F., Mbui, J., Sigilai, A., ... & Barasa, E. (2019). Patient costs of hypertension care in public health care facilities in Kenya. The International journal of health planning and management, 34(2), e1166-e1178.

Unadike, B.C, Essien I., Akpan, N.A., Peters, E.J., & Essien O.E.(2013). Profile Outcome of Diabetic admissions at the University of Uyo Teaching Hospital, Uyo.International Journal of Medicine and Medical Sciences 5(6), 286-289.

Wagstaff, A., & Doorslaer,V.(2002). Catastrophic and Impoverishment in paying or Healthcare: With Application to Vietnam1993-98. Health Economics, 12(11): 921-934.

Wang, G. , Zhou, X., Zhuo, X., Zhang, P.(2017). Annual Total Expenditures Associated with Hypertension by Diabetes Status in US. Adults. Am J Prev Med 2017; 53(6s2): S182-S189.

Webb, M.C., & Conrad, D.A.(2012). The Cost of Treating Chronic Non communicable Diseases: Does it Matters? The University of West Indies at St Augustine. 42520. 1-14.

World Health Organization. (2013). A global brief on hypertension: silent killer, global public health crisis: World Health Day 2013 (No. WHO/DCO/WHD/2013.2). World Health Organization.

WHO, (2019). Fact on the prevalence of hypertension. Retrieved from on April 29, 2020.

Xu, K., Evans, D., Karrin, G., & Aguilar-Rivera, A. M. (2005). Technical Brief for Policy Makers. Designing health financing systems to reduce catastrophic health expenditure. World Health Organization, Department of Health Systems Financing, Health Financing Policy, 1-4.

Yang, Y., Tang, Y., Jiang, H., Chen, Y., Wan, P., Fan, M., ... & Lao, M. (2019). 2020 Roadmap on gas-involved photo-and electro-catalysis. Chinese Chemical Letters, 30(12), 2089-2109.




How to Cite

Idris Abubakar, & Obansa S.A.J. (2020). An Estimate of Average Cost of Hypertension and its catastrophic effect on the people living with hypertension: Patients’ perception from two Hospitals in Abuja, Nigeria. International Journal of Social Sciences and Economic Review, 2(2), 10-19.